Display options
Cite
Leppig KA, Thiese HA, Carrel D, et al. Building a family network from genetic testing. Mol Genet Genomic Med. 2016;5(2):122-129doi: 10.1002/mgg3.259.
Leppig, K. A., Thiese, H. A., Carrel, D., Crosslin, D. R., Dorschner, M. O., Gordon, A. S., Hartzler, A., Ralston, J., Scrol, A., Larson, E. B., & Jarvik, G. P. (2017). Building a family network from genetic testing. Molecular genetics & genomic medicine, 5(2), 122-129. https://doi.org/10.1002/mgg3.259
Leppig, Kathleen A, et al. "Building a family network from genetic testing." Molecular genetics & genomic medicine vol. 5,2 (2017): 122-129. doi: https://doi.org/10.1002/mgg3.259
Leppig KA, Thiese HA, Carrel D, Crosslin DR, Dorschner MO, Gordon AS, Hartzler A, Ralston J, Scrol A, Larson EB, Jarvik GP. Building a family network from genetic testing. Mol Genet Genomic Med. 2016 Dec 29;5(2):122-129. doi: 10.1002/mgg3.259. eCollection 2017 Mar. PMID: 28361098; PMCID: PMC5370219.
Copy Download .nbib Format: NLM
Share it on

Mol Genet Genomic Med. 2016 Dec 29;5(2):122-129. doi: 10.1002/mgg3.259. eCollection 2017 Mar.

Building a family network from genetic testing.

Molecular genetics & genomic medicine

Kathleen A Leppig, Heidi A Thiese, David Carrel, David R Crosslin, Michael O Dorschner, Adam S Gordon, Andrea Hartzler, James Ralston, Aaron Scrol, Eric B Larson, Gail P Jarvik

Affiliations

  1. Genetic ServicesGroup Health CooperativeSeattleWA98112USA; Department of PathologyUniversity of WashingtonSeattleWA98195USA.
  2. Genetic Services Group Health Cooperative Seattle WA 98112 USA.
  3. Group Health Research Institute Group Health Cooperative Seattle WA 98101 USA.
  4. Department of Biomedical Informatics and Medical Education University of Washington Seattle WA 98195 USA.
  5. Department of Pathology University of Washington Seattle WA 98195 USA.
  6. Department of Medicine (Medical Genetics) and Genomic Sciences University of Washington Seattle WA 98195 USA.

PMID: 28361098 PMCID: PMC5370219 DOI: 10.1002/mgg3.259

Abstract

BACKGROUND: Genetic testing has multigenerational and familial repercussions. However, the "trickle-down effect" of providing genetic counseling and testing to family members at risk after an initial identification of a pathogenic variant in a medically actionable gene has been poorly understood.

METHODS: Three probands were identified during the pharmacogenetics research phase of eMERGEII (electronic MEdical Record and Genomics, phase II) to have variants in genes associated with autosomal dominant adult-onset disorders determined to be actionable by the American College of Medical Genetics (ACMG). Two of the three probands had variants that were classified as pathogenic and the third proband had a variant ultimately classified of uncertain significance, but of concern due to the proband's own phenotype. All probands had additional family members at risk for inheriting the variant. Two of the three probands had family members who received their medical care from the same health care system, Group Health Cooperative (GHC). It was recommended that the proband contact their family members at risk to be referred to genetic counseling for consideration of genetic testing.

RESULTS: The two probands with pathogenic variants contacted some of their family members at risk. Individuals contacted included children and adult grandchildren, particularly if they received their medical care at GHC. To the best of our knowledge, siblings and more distant relatives at risk were not informed by the proband of their genetic risk.

CONCLUSIONS: Establishing a family network is essential to disseminate knowledge of genetic risk. These three initial cases describe our experience of contacting eMERGE participants with identified variants, providing the probands with appropriate genetic counseling and care coordination, and recommendations for contacting family members at risk. Greater challenges were observed for coordinating genetics care for family members and extending the family network to include other relatives at risk.

Keywords: Electronic medical record and genomics; LDLR; RYR1; SCN5A; family network

References

  1. Paediatr Anaesth. 2013 Sep;23(9):834-41 - PubMed
  2. J Clin Oncol. 2015 Jun 20;33(18):2084-91 - PubMed
  3. Atherosclerosis. 2012 Aug;223(2):401-8 - PubMed
  4. BMC Med Genomics. 2011 Jan 26;4:13 - PubMed
  5. J Med Genet. 2006 Oct;43(10):817-21 - PubMed
  6. PLoS One. 2012;7(8):e42037 - PubMed
  7. Clin Pharmacol Ther. 2016 Aug;100(2):160-9 - PubMed
  8. Br J Anaesth. 2016 Apr;116(4):566-8 - PubMed
  9. Anesthesiology. 2013 Nov;119(5):1043-53 - PubMed
  10. Brain Pathol. 2011 Mar;21(2):201-8 - PubMed
  11. JAMA. 2004 Sep 22;292(12):1469-73 - PubMed
  12. Heart Rhythm. 2014 Jun;11(6):1015-23 - PubMed
  13. Nature. 2016 Aug 17;536(7616):285-91 - PubMed
  14. Genet Med. 2017 Feb;19(2):176-181 - PubMed
  15. Genomics. 1991 Nov;11(3):751-5 - PubMed
  16. Genet Med. 2016 Jan;18(1):3-12 - PubMed
  17. Health Commun. 2016;31(6):668-78 - PubMed
  18. J Clin Oncol. 2006 Feb 1;24(4):700-6 - PubMed
  19. Epilepsy Res. 2013 Aug;105(3):415-8 - PubMed
  20. Pharmacogenet Genomics. 2016 Jan 5;:null - PubMed
  21. Am J Hum Genet. 2014 Jun 5;94(6):818-26 - PubMed
  22. Genet Med. 2013 Jul;15(7):565-74 - PubMed

Publication Types

Grant support